May 7, 2020 | News, Press Release
Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic Partnership New alliance designed to enhance the lives of people living with sickle cell disease HANOVER, Md. and LEXINGTON, Mass., May 6, 2020 Sickle Cell Disease Association of...
Nov 1, 2019 | News, Press Release
Hemanext Announces CE Mark Submission for the HEMANEXT ONE Red Blood Cell Processing System Regulatory filing is a major step toward commercialization of transfusion-medicine innovation LEXINGTON, Mass., November 1, 2019 Hemanext Inc., a privately held medical...
Oct 24, 2019 | News, Press Release
Hemanext Announces Publication of Data Demonstrating Significant Benefits Following the Transfusion of Hypoxically Stored Red Blood Cells LEXINGTON, Mass., October 24, 2019 Hemanext, a privately held medical technology company dedicated to improving the quality,...
Oct 3, 2019 | News, Press Release
Hemanext to Present Extensive, Significant Red Blood Cell Data at AABB 2019 AABB accepted all eight research abstracts for presentation at annual conference October 3, 2019 Hemanext, a privately held medical technology company dedicated to creating a world with fewer...
Jun 6, 2019 | News, Press Release
Hemanext will be exhibiting at the upcoming Remote Damage Control Resuscitation (RDCR) Symposium, taking place June 23 – 26, 2019 in Osøyro, Norway. The RDCR Symposium is organized by THOR – The Hemostasis and Oxygen Research Network. THOR is an international...
Nov 26, 2018 | News, Press Release
Hemanext recently attended the Blood 2018 meeting which is a conference combining the Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Australian and New Zealand Society of Blood Transfusion and the Thrombosis and Haemostasis society...
